Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
2024-12-20

DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. $(NVAX)$ inched 0.58% higher to $8.68 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.04% to 42,342.24 and the NASDAQ Composite Index falling 0.10% to 19,372.77.

The stock's rise snapped a two-day losing streak.

Novavax Inc. closed $15.18 below its 52-week high ($23.86), which the company reached on June 6th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.81% to $143.58, Pfizer Inc. $(PFE)$ fell 0.46% to $25.77, and Merck & Co. Inc. $(MRK)$ rose 1.20% to $99.52.

Trading volume (3.6 M) remained 1.8 million below its 50-day average volume of 5.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 19, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

December 19, 2024 17:36 ET (22:36 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10